$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cara Therapeutics, Inc. - CARA

Group 1 - Monteverde & Associates PC is investigating Cara Therapeutics, Inc. regarding its proposed merger with Tvardi Therapeutics, Inc. [1] - Under the merger agreement, Cara Therapeutics stockholders are expected to own approximately 17.0% of the combined company [1] - Monteverde & Associates PC has a successful track record in recovering millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report [1][3] Group 2 - The firm is headquartered in the Empire State Building in New York City [1][3] - Monteverde & Associates PC is a national class action securities firm with experience in trial and appellate courts, including the U.S. Supreme Court [3]